Clinical Trial

Artificial Intelligence-Based Motion Analysis for Early Detection of COPD

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 8, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to develop a non-invasive and contact-free diagnostic system that uses artificial intelligence (AI) to detect Chronic Obstructive Pulmonary Disease (COPD) by analyzing walking patterns. Participants in this study will include individuals with a diagnosis of COPD and healthy volunteers. All participants will undergo a 6-minute walk test (6MWT), during which their movements will be recorded using video. In addition, they will complete a breathing test (spirometry) and a short questionnaire about symptoms. The recorded videos will be analyzed using an AI model based on motion tracking software. This model will evaluate walking-related parameters such as step count, step length, walking time, and total walking distance. The goal is to determine whether walking patterns can be used to detect COPD with high accuracy, especially in situations where traditional lung function tests may not be available or feasible. This study is observational and does not involve any experimental drug or treatment. The results may help to create new diagnostic tools that are easy to use, safe, and accessible for early detection of COPD.
Trial Details
NCT Number NCT07010211
Lead Sponsor Burcin Celik
Collaborators: Ondokuz Mayıs University
Conditions Chronic Obstructive Pulmonary Disease (COPD)
Enrollment 56 participants
Start Date 2025-08-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-08